Trends in Pediatric Primary Care Visits Among Commercially Insured US Children, 2008-2016

Kristin N Ray1, Zhuo Shi2, Ishani Ganguli3,4

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

JAMA Pediatrics
|January 22, 2020
PubMed

Insights

Pediatric primary care visits declined 14.4% from 2008-2016, with problem-based visits dropping significantly. Rising out-of-pocket costs and increased use of alternative care settings contributed to this trend in children's healthcare.

Area of Science:

  • Pediatric Health Services Research
  • Healthcare Utilization Trends
  • Health Economics

Background:

  • Primary care serves as the cornerstone of pediatric healthcare delivery.
  • Previous policy efforts have concentrated on enhancing access and quality of pediatric primary care.
  • However, comprehensive data on the overall trends in primary care utilization among children remain limited.

Purpose of the Study:

  • To analyze trends in primary care visit rates and associated out-of-pocket expenses for children.
  • To investigate how these trends vary based on patient and visit characteristics.
  • To evaluate the extent of shifts towards alternative care options, including retail clinics, urgent care centers, and telemedicine.

Main Methods:

  • An observational cohort study utilizing claims data from a large national commercial health plan.
  • Data encompassed children aged 17 years and younger from 2008 to 2016.
  • Primary care visit rates per 100 child-years were calculated and analyzed using Poisson models, controlling for demographic shifts.

Main Results:

  • A significant decrease in primary care visit rates was observed, declining by 14.4% overall from 2008 to 2016.
  • While preventive care visits increased by 9.9%, problem-based visits decreased by 24.1%.
  • Out-of-pocket costs for problem-based visits rose by 42%, and visits to other acute care venues and specialists increased by 30.3% and 16.4%, respectively.

Conclusions:

  • Pediatric primary care visit rates have declined among commercially insured children over the past decade.
  • Increased out-of-pocket costs and a growing preference for alternative care settings appear to be key factors driving this trend.
  • Understanding these shifts is crucial for future pediatric healthcare policy and resource allocation.
Abstract

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
165
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
151
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
198